immunity News and Research

RSS

Controlled TB vaccine trial designed to study prevention of Mtb infection by vaccination

Aeras today announced the initiation of the first randomized, controlled tuberculosis (TB) vaccine trial designed to study prevention of Mycobacterium tuberculosis (Mtb) infection by vaccination.

11 Mar 2014

Professors receive $31M grant to establish Center for Research in Diagnostics and Discovery

W. Ian Lipkin, director of the Center for Infection and Immunity and John Snow Professor of Epidemiology at the Mailman School of Public Health, has received an award of up to $31 million over a five-year period by the National Institutes of Health (NIH) to establish the Center for Research in Diagnostics and Discovery (CRDD) under the auspices of a new National Institute of Allergy and Infectious Diseases (NIAID) program entitled Centers of Excellence for Translational Research.

11 Mar 2014

Sleep apnoea may be risk factor for pneumonia

People who suffer from sleep apnoea face an increased risk of developing pneumonia, a large epidemiological study indicates.

10 Mar 2014

Viewpoints: New delay on policies: Cover for dems or just smoothing the bumps of health law?

The Obama administration announced a new policy on Wednesday that will allow many people to renew their existing insurance policies for two more years even though the policies don't provide the comprehensive coverage and consumer protections required by the Affordable Care Act.

10 Mar 2014

Warmer temperatures allow malaria to spread to higher elevations

Malaria, a mosquito-borne disease, infects more than 300 million people each year. Cooler highland regions have historically provided havens from malaria, but it has been predicted that the disease could be especially sensitive to climate change, since both the Plasmodium parasites that cause it and the Anopheles mosquitoes that spread it thrive at warm temperatures. The potential impact of global warming on the worldwide incidence of malaria has been debated for more than two decades.

7 Mar 2014

Researcher wins grant from NCI to continue developing new therapy for bladder cancer

A biomedical engineering researcher at the University of Arkansas will use a $416,897 grant from the National Cancer Institute to continue developing a new therapy for bladder cancer.

6 Mar 2014

Six papers published by PNAS in 2013 to receive Cozzarelli Prize

The Proceedings of the National Academy of Sciences (PNAS) Editorial Board has selected six papers published by PNAS in 2013 to receive the Cozzarelli Prize, an award that recognizes outstanding contributions to the scientific disciplines represented by the National Academy of Sciences.

6 Mar 2014

Researchers awarded $26M NIH grant to advance treatments for Ebola and Marburg

The University of Texas Medical Branch at Galveston, Profectus Biosciences, Tekmira Pharmaceuticals and the Vanderbilt University Medical Center have been awarded up to $26 million to advance treatments of the highly lethal hemorrhagic fever viruses Ebola and Marburg.

6 Mar 2014

Study to understand role of bacterium in heart valve disease

A disease-causing bacterium found in the mouth needs manganese, a trace mineral, in order to cause a serious heart infection, according to a preclinical study led by researchers at Virginia Commonwealth University Philips Institute for Oral Health Research in the School of Dentistry.

6 Mar 2014

Specific protein has vital role in controlling symptoms of allergic asthma, say researchers

An enzyme that helps maintain immune system function by "throwing away" a specific protein has a vital role in controlling symptoms of allergic asthma, new research in mice suggests.

6 Mar 2014

Chemotherapy induces long-lasting epigenetic changes in survivors' blood cells

Many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended.

5 Mar 2014

A-PARADDISE consortium obtains funds to develop innovative therapies for neglected parasitic diseases

The international consortium A-PARADDISE (Anti-Parasitic Drug Discovery in Epigenetics), coordinated by Inserm, has just obtained funds of €6 million from the European Commission to conduct large-scale testing of innovative therapies against four neglected parasitic diseases: schistosomiasis, leishmaniasis, Chagas disease and malaria.

4 Mar 2014

Study: Self-administration of flu vaccines with microneedle patches may one day be feasible

The annual ritual of visiting a doctor's office or health clinic to receive a flu shot may soon be outdated, thanks to the findings of a new study published in the journal Vaccine.

4 Mar 2014

Washington University professor to receive AACR-CRI Lloyd J. Old Award in Cancer Immunology

The American Association for Cancer Research (AACR) and the Cancer Research Institute (CRI) will present Robert D. Schreiber, Ph.D., Alumni Endowed Professor of Pathology and Immunology, Professor of Molecular Microbiology, and Director of the Center for Human Immunology and Immunotherapy Programs at Washington University School of Medicine in St. Louis, Mo., with the second annual AACR-CRI Lloyd J. Old Award in Cancer Immunology at the AACR Annual Meeting 2014, to be held in San Diego, Calif., April 5-9.

3 Mar 2014

Researchers discover novel treatments for psoriasis that are likely to cause fewer side effects

Almost ten years ago, the group led by Erwin Wagner, currently at the Spanish National Cancer Research Centre (CNIO), developed genetically modified mice showing symptoms very reminiscent to psoriasis.

28 Feb 2014

Study: Direct camel-to-human transmission of MERS virus is possible in Saudi Arabia

An estimated three-quarters of camels recently surveyed in Saudi Arabia have evidence of infection with the Middle East Respiratory Syndrome coronavirus (MERS-CoV), the virus responsible for human cases of MERS.

27 Feb 2014

Researchers discover new target for human antibodies that holds key to vaccine for dengue

Creating a vaccine that protects people from all four types of dengue virus has frustrated scientists for decades. But researchers at the University of North Carolina have discovered a new target for human antibodies that could hold the key to a vaccine for the world's most widespread mosquito-borne disease.

27 Feb 2014

immunity News and Research

Controlled TB vaccine trial designed to study prevention of Mtb infection by vaccination

Professors receive $31M grant to establish Center for Research in Diagnostics and Discovery

Sleep apnoea may be risk factor for pneumonia

Viewpoints: New delay on policies: Cover for dems or just smoothing the bumps of health law?

Warmer temperatures allow malaria to spread to higher elevations

Researcher wins grant from NCI to continue developing new therapy for bladder cancer

Six papers published by PNAS in 2013 to receive Cozzarelli Prize

Researchers awarded $26M NIH grant to advance treatments for Ebola and Marburg

Study to understand role of bacterium in heart valve disease

Specific protein has vital role in controlling symptoms of allergic asthma, say researchers

Chemotherapy induces long-lasting epigenetic changes in survivors' blood cells

A-PARADDISE consortium obtains funds to develop innovative therapies for neglected parasitic diseases

Study: Self-administration of flu vaccines with microneedle patches may one day be feasible

Washington University professor to receive AACR-CRI Lloyd J. Old Award in Cancer Immunology

Researchers discover novel treatments for psoriasis that are likely to cause fewer side effects

Study: Direct camel-to-human transmission of MERS virus is possible in Saudi Arabia

Researchers discover new target for human antibodies that holds key to vaccine for dengue

Highlights: Ky. malpractice bill; Texas punishes doc under abortion law; DOJ enters whistleblower case

University of Texas researchers reveal ancient mysteries behind leprosy

Taste receptors act as first line sentinels against infection in upper airway

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News